F Sahebi, R Spielberger, NM Kogut, H Fung, PM Falk, P Parker, A Krishnan, R Rodriguez, R Nakamura, A Nademanee, L Popplewell, P FrankelC Ruel, R Tin, P Ilieva, SJ Forman, and G Somlo: Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma. Bone Marrow Transplantation May 2006, 37: 825-829.
Nademanee, A., Forman, F., Molina, A., Fung, H., Smith, D., Dagis, A., Kwok, C., Yamauchi, D., Anderson, A.L., Falk, P., Krishnan, A., Kirschbaum, M., Kogut, K., Nakamura, R., O'Donnell, M., Parker, P., Popplewell, L., Pullarkat, V., Rodriguez, R., Sahebi, F., Smith, E., Snyder, D., Stein, A., Spielberger, R., Zain, J., White, C., and Raubitschek, A.: A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma Blood, 15 October 2005, Vol. 106, No. 8, pp. 2896-2902.
Lopez F, Parker P, Nademanee, A, Rodriguez, Al-Kadhimi, Z. Bhatia R, Cohen S,Falk P, Fung H, Kirschbaum M, Krishnan A, Kogut N, Molina A, Nakamura R, O’Donnell M, Popplewell L, Pullarkat V, Rosenthal R, Sahebi F, Smith E, Snyder E, Somlo G, Spielberger R, Stein A, Sweetman R, Zain, J and Forman S. Efficacy of Mycophenolate Mofetil (MMF) in the Treatment of Chronic Graft Versus Host Disease. BBMT 11:307-313 2005.
Parikh, Cr., Sandmaier, BM., Storb., RF., Blume, KF., Sahebi, F. Maloney, D., Maris, MB., Nieto, Y., Edelstein, CL., Schrier, RW., McSweeney P.: Acute renal failur after nonmyeloablative hematopoietic cell transplantation. J Am Soc Nephrol. 2004 Jul;15(7):1868-76.
Rodriguez, R., Parker, P., Nademanee, A., Smith, D., O’Donnell MR., Stein A., Snyer DS., Fung HC., Krishnan AY., Popplewell L., Cohen S., Somlo G., Angelopoulou M., Al-Kadhimi Z., Falk PM., Spielberger R., Kogut N., Sahebi, F., Senitzer, D., Slovak, M., Schriber, J., Forman, S.J.: Cyclosporine and mycopyhenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies. Bone Marrow Transplant. 2004 June;33(11):1123-9
Maloney, D., Molina, A., Sahebi, F., Allografting with non-myeloalative conditioning following cyto reductive autografts for the treatment of patients with multiple myeloma. Blood, Nov 2003, Vol. 102. No 9. p3447-3454.
Sahebi, F., Somlo, G., Kogut, N., Feasibility and toxicity of maintenance Thalidomide following single cycles autologous PBSC transplant in patients with multiple myeloma, Abstract #3662, Blood, Vol. (11), Nov 2003.
Fung, H.C., Stein, F., Slovak, M.L., O’Donnell, M.R., Snyder, D.S., Cohen, S., Smith, D., Krishnan, A., Spielberger, R., Bhatia, R., Bhatia S., Falk, P., Molina, A., Nademanee, A., Parker, P., Rodriguez, R., Rosenthal, J., Sweetman, R., Kogut, N., Sahebi, F., Popplewell, L., Vora, N., Somlo, G., Margolin, K., Chow, W., Smith, E., and Forman, S.J. A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: Impact of cytogenetic characteristics on transplantation outcome. Biology of Blood and Marrow Transplantation, 9: 766-771, 2003.
Fung, H.C., Cohen, S., Rodriguez, R., Smith, D., Krishnan, A., Somlo, G., Sahebi, F., Senitzer, D., O’Donnell, M. R., Stein, A., Snyder, D.S., Spielberger, R., Bhatia, R., Falk, R., Molina, A., Nademanee, A., Parker, P., Kogut, N., Popplewell, L., Vora, N., Margolin, K., and Forman, S.J. Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed. Biology of Blood and Marrow Transplantation, 9:649-656, 2003.
George, G.E., Masris, M., Sandmaier, B.M., Maloney, D. G., Feinstein, L., Niederweiser, D., Shizuru, J.A., McSweeney, P.A., Chauncey, T.R., Agura, E., Little, M.T., Sahebi, F., Hegenbart, U., Pulsipher, M.A., Bruno, B., Forman, S., Wopolfrey, A.E., Radich, J.P., Blue, K.G., and Storb, R. Related and unrelated non-myeloablative hemaopoetic stem cell transplantation for malignant diseases. International Journal of Hematology, 76: 184-189, 2002.
Stewart, A.K., Vescio R., Schiller G., Ballester, O., Noga, S., Rugo H., Freytes C, Stadtmauer E, Tarantolo S., Sahebi F., Stiff, P. Meharchard, J, Schlossman, R., Brown, R., Tully, H., Benyunes M., Jacobs, C., Berenson, R., White M., DiPersio J., Anderson, K. C.: Berenson J.: Purging of Autologous Peripheral-Blood Stem Cells Using CD34 Selection Does Not Improve Overall or Progression-Free Survival After High-Dose Chemotherapy for Multiple Myeloma: Results of a Multicenter Randomized Controlled Trial, Journal of Clinical Oncology, Vol 19, Issue 17 (September), 2001:3771-3779.
Sandmeir, B.M., Maloney, D.G., Hegenbart, U, Sahebi, F. Non myeloablative allogeneic stem cell transplantation for hematologic malignancies, Abstracts # 2053, 2062, 2239, 2243, Blood, Nov, 2000, vol. 96, No 11.
Molina, A, Sahebi, F., Maloney, D.G., Non myeloablative peripheral blood stem cell allografts following cytoreductive autotransplants for treatment of multiple myeloma, abstract # 2063, Blood, Nov 2000, vol. 96, No 11.
Vescio, RA., Wu, CH., Zheng, L., Sheen, D., Stewart, AK., Sahebi F., Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograft products from multiple myeloma patients , Bone Marrow Transplant, 2000, 25, p153 160
Vescio, R., Schiller, G,, Stewart., K, Sahebi, F., Multicenter phase III trial to evaluate CD 34 + selected vs unselected autologous PB cell transplantation in Multiple myeloma Blood, March 15, 1999, 93(6), P1858 1868
Freytes, C., Stewart, AK., Vescio, R., Schiller, G., Stiff, P, Sahebi F., CD 34 selection did not delay immune recovery nor increase frequency of infections in multiple myeloma patients transplanted in a phase III trial, Abstract #2724, Blood 92(10) Suppl I Nov. 1998
Stewart, AK., Vescio, R., Schiller, G., Ballester, O., Sahebi, F., Phase III study evaluating CD 34 selected vs unselected autologous PBPC transplant in 190 patients with advanced multiple myeloma, Abstract # 2733, Blood 92(10) Suppl I Nov. 1998
Nomura, J., Ruskin, J., Sahebi, F., Mucormycosis of the vulva following BMT, Bone marrow transplantation, April 1997, 19(8), P 859
Sahebi, F., Crilley, P., Copelan, E, Unrelated allogeneic bone marrow transplantation using high dose Busulfan and Cyclophosphamide (BU CY) conditioning regimen, Bone marrow transplantation, May 1996, vl. 17(5), p 685 689.
Schiller, G., Vescio, R., Fretus, C., Sahebi, F.,Transplantation of CD 34 positive peripheral blood progenitor cells following high dose chemotherapy for patients with advanced multiple myeloma, Blood, July 1995, vol. 86(1), p390 397.
Sahebi, F., Kunkel, L., Territo, M., Belin, T., Naeim, F., The result of treatment in 51 patients with acute biphenotypic leukemia, American Society of Clinical Oncology Proceeding, abstract 1005, May 1994.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 06/08.
